Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
3
×
national blog main
boston blog main
boston top stories
detroit blog main
detroit top stories
eli lilly
genentech
national top stories
san francisco blog main
san francisco top stories
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avapritinib
avexis
bempedoic acid
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
cholesterol
clostridium difficile
community-acquired bacterial pneumonia
What
fda
3
×
regulatory
3
×
drug
medicines
wins
approval
approved
august
bio
biotech
blueprint
busy
cancer
candidate
cholesterol
combo
currently
days
decisions
devices
drugs
esperion
esperion’s
legacy
levels
lowering
marketing
muscle
news
nod
nods
opioid
pact
pairs
past
pill
ret
review
roche
roundup
Language
unset
3
×
Current search:
regulatory
×
fda
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More